Summary
Keysight Technologies, Inc. reported strong net revenue growth of 22% to $3.88 billion for the fiscal year ended October 31, 2018, up from $3.19 billion in 2017. This growth was significantly driven by acquisitions, including Ixia, which expanded the company's offerings in network test and visibility solutions. The Communications Solutions Group and Electronic Industrial Solutions Group showed robust performance, with the latter benefiting from strong demand in automotive and energy sectors. However, the company incurred a substantial goodwill impairment charge of $709 million related to the Ixia Solutions Group, leading to a net loss of $165 million for the year, a significant decrease from the $102 million net income in the prior year. Despite the net loss, operating cash flow remained strong at $555 million, and the company ended the year with a healthy cash position. Keysight continues to invest in R&D for future growth, particularly in areas like 5G and autonomous vehicles.
Financial Highlights
55 data points| Revenue | $3.88B |
| Cost of Revenue | $1.77B |
| Gross Profit | $2.11B |
| R&D Expenses | $624.00M |
| SG&A Expenses | $1.21B |
| Operating Expenses | $4.27B |
| Operating Income | -$394.00M |
| Interest Expense | $83.00M |
| Net Income | $165.00M |
| EPS (Basic) | $0.88 |
| EPS (Diluted) | $0.86 |
| Shares Outstanding (Basic) | 187.00M |
| Shares Outstanding (Diluted) | 191.00M |
Key Highlights
- 1Net revenue increased by 22% to $3.88 billion in FY2018, driven by acquisitions and organic growth across segments.
- 2The Ixia Solutions Group, acquired in April 2017, contributed significantly to revenue growth, although it also led to a substantial goodwill impairment of $709 million.
- 3Communications Solutions Group and Electronic Industrial Solutions Group demonstrated strong revenue growth, particularly in commercial communications (driven by 5G) and automotive/energy markets, respectively.
- 4Operating cash flow was robust at $555 million, indicating strong operational cash generation.
- 5The company maintained a healthy cash and cash equivalents balance of $913 million as of October 31, 2018.
- 6Research and development expenses increased by 22% year-over-year, reflecting continued investment in innovation.
- 7Despite revenue growth, a significant goodwill impairment charge resulted in a net loss of $165 million for FY2018, compared to a net income of $102 million in FY2017.